查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1946401

山奈酚市场研究－全球产业规模、份额、趋势、机会及预测（依纯度、应用、地区及竞争格局划分，2021-2031年）

Kaempferol Market Research Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Purity, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球山奈酚市场预计将从 2025 年的 46.8 亿美元成长到 2031 年的 62.8 亿美元，复合年增长率为 5.02%。

这种天然存在于羽衣甘蓝、茶叶、菠菜、豆类和西兰花等植物中的黄酮醇抗氧化剂，因其抗发炎和抗癌特性，正日益被应用于医药和营养保健品领域。市场成长的主要驱动力是全球对机能性食品配料的需求不断增长，以及越来越多的临床研究探索类黄酮在慢性病管理中的有效性。植物产业的强劲表现也进一步支撑了这一成长，该产业是重要的商业管道。例如，美国植物委员会 (ABC) 报告称，预计到 2024 年，美国草药营养保健品的零售额将达到 132.3 亿美元，这凸显了消费者对植物来源预防医学的转变，并推动了对高纯度植物化学物质的需求。

市场概览
预测期 2027-2031
市场规模：2025年 46.8亿美元
市场规模：2031年 62.8亿美元
复合年增长率：2026-2031年 5.02%
成长最快的细分市场 製药
最大的市场 北美洲

儘管存在这些积极趋势，但市场在实现大规模生产的成本效益方面仍面临许多障碍。从生物质原料中提取高纯度山奈酚製程复杂，且通常回收率较低，这不仅显着增加了生产成本，也限制了其在大众消费品市场的供应。这种经济障碍限制了山奈酚在价格敏感领域（例如化妆品和机能饮料）的广泛应用，可能导致製造商选择价格较低的合成替代品或品质较低的萃取物。因此，生产商面临着持续的挑战，即如何改进提取技术，以在保持价格竞争力的同时，满足製药和高端营养保健品行业严格的纯度标准。

市场驱动因素

全球癌症和慢性疾病发生率的不断上升是推动全球山奈酚市场发展的主要动力，加速了先进治疗性介入的研发。山奈酚因其强大的抗氧化机製而日益受到重视，该机制对于对抗与心血管疾病和致癌作用相关的氧化压力至关重要。随着製药公司在药物研发中优先考虑天然生物活性成分，将高纯度山奈酚纳入肿瘤治疗研发管线的趋势日益明显。美国癌症协会于2025年1月发布的《2025年癌症事实与数据》报告强调了这种临床紧迫性，该报告预测，2025年美国将新增约2,041,910例癌症病例。此外，世界卫生组织（WHO）于2025年5月发布的《2025年世界卫生统计》报告预测，每年至少有4,300万人死于非传染性疾病，这进一步凸显了全球对易于取得的植物来源医疗解决方案的需求。

同时，消费者对植物来源保健品的态度转变正在推动富含山奈酚的膳食补充剂的需求，并重塑市场格局。这一趋势正将类黄酮的商业性用途从小众医疗领域拓展到主流机能性食品，用于促进代谢健康和增强免疫力。製造商正在产品中添加高生物利用度的山奈酚，以吸引註重健康、追求成分洁净标示的消费者。这种强劲的消费者需求得益于消费者对植物来源产品的整体偏好。根据良好食品研究所（Good Food Institute）于2025年6月发布的《2024年产业趋势报告》，全球植物来源肉品、鱼贝类和乳製品的零售额将达到286亿美元，为将山奈酚等功能性植物成分融入日常消费品提供了广阔的发展空间。

市场挑战

大规模生产的经济可行性是限制全球山奈酚市场扩张的主要直接障碍。高纯度山奈酚的提取涉及复杂的製程，且从植物中回收的效率通常较低，这必然会增加生产成本。高昂的营运成本迫使供应商对山奈酚收取高价，显着降低了其在利润微薄的大众市场应用中的吸引力。因此，一般机能性食品和饮料行业的开发商往往倾向于选择价格更实惠的合成抗氧化剂，而放弃使用山奈酚。这使得山奈酚的商业性应用仅限于高端专业产品，使其难以进入大众市场。

价格限制导致供给能力与消费者对预防性保健解决方案的强劲需求之间存在不匹配。儘管保健产品需求广泛，但由于无法以经济有效的方式生产山奈酚，它难以成为日常保健的必备成分。近期行业数据显示，这项尚未开发的市场规模庞大：负责任营养委员会 (CRN) 报告称，到 2024 年，75% 的美国人将使用膳食补充剂。虽然如此高的普及率意味着庞大的潜在客户群，但高纯度山奈酚的高昂成本阻碍了其渗透到如此广泛的消费群体，从而有效地限制了市场的整体成长速度。

市场趋势

基于代谢工程的生物合成生产的兴起改变了高价值类黄酮的价值链，克服了传统农业萃取方法的局限性。与受季节性波动和产量低影响的溶剂萃取方法相比，利用基因改造细菌和酵母的微生物发酵平台正日益成为主流，能够稳定生产药用级山奈酚。这项技术进步使得生物活性化合物的规模化生产不再依赖植物生物质，从而确保了工业需求的稳定供应。这一生产模式的转变获得了雄厚的资金支持。根据SynBioBeta于2025年5月发布的《2025年投资报告》，预计2024年合成生物学领域的创投将回升至122亿美元，显示市场对生物製造技术充满信心。

同时，山奈酚被广泛应用于洁净标示抗衰老护肤产品中，使其商业性范围从膳食补充剂拓展至盈利的个人护理市场。配方师着眼于山奈酚的许多特性，例如减少紫外线引起的皮肤损伤和中和活性氧，积极将其融入高端外用产品中，以满足消费者对科学验证的植物来源美容解决方案日益增长的需求。鑑于美容产业的规模和韧性，这一细分市场蕴藏着巨大的市场渗透潜力。根据2025年6月发布的《2024年欧洲化妆品年度报告》，预计到2024年，欧洲个人护理和化妆品市场零售额将达到1040亿欧元，这将为山奈酚等功能性生物活性成分建立起庞大而稳定的需求基础。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球山奈酚市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 依纯度（10%、20%、50%、95%、98%）
    • 依应用领域（食品饮料、化妆品、药品、营养补充品等）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

6. 北美山奈酚市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲山奈酚市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区山奈酚市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲山奈酚市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章 南美洲山奈酚市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球山奈酚市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Aktin Chemicals Inc
  • PromoCell.
  • Cambridge Isotope Laboratories.
  • FoodChem.
  • Shaanxi NHK Technology.
  • Spectrum Chemical Mfg. Corp.
  • LGC Standards.
  • FUJIFILM Wako Chemicals USA Corporation.
  • AppliChem GmbH.
  • Qingdao Hosun Biological Technology Co. Ltd

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 21442

The Global Kaempferol Market is projected to expand from USD 4.68 Billion in 2025 to USD 6.28 Billion by 2031, registering a compound annual growth rate of 5.02%. Naturally occurring in plants such as kale, tea, spinach, beans, and broccoli, this flavonol antioxidant is increasingly adopted by the pharmaceutical and nutraceutical sectors for its anti-inflammatory and anticancer capabilities. The market's upward trajectory is primarily driven by the rising global demand for functional dietary ingredients and the growing number of clinical studies exploring flavonoids for chronic disease management. This growth is further supported by the strong performance of the botanical industry, which acts as a crucial commercial channel; for instance, the American Botanical Council reported that U.S. retail sales of herbal dietary supplements reached an estimated 13.23 billion dollars in 2024, highlighting a consumer shift toward plant-based preventative health that fuels the demand for high-purity phytochemicals.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.68 Billion
Market Size 2031USD 6.28 Billion
CAGR 2026-20315.02%
Fastest Growing SegmentPharmaceuticals
Largest MarketNorth America

Despite these positive trends, the market encounters a substantial obstacle regarding the cost-effectiveness of mass production. Extracting high-purity kaempferol from raw biomass is a technically intricate process that often yields low recovery rates, significantly raising manufacturing expenses and restricting its availability for mass-market consumer products. This economic barrier limits widespread adoption in price-sensitive areas like cosmetic formulations and functional beverages, where manufacturers may opt for affordable synthetic substitutes or lower-grade extracts. Consequently, producers face the ongoing challenge of refining extraction technologies to balance competitive pricing with the rigorous purity standards mandated by the pharmaceutical and premium nutraceutical industries.

Market Driver

The rising global incidence of cancer and chronic diseases serves as a major catalyst for the Global Kaempferol Market, accelerating the creation of advanced therapeutic interventions. Kaempferol is increasingly acknowledged for its powerful antioxidant mechanisms, which are essential in neutralizing the oxidative stress associated with cardiovascular conditions and oncogenesis. As pharmaceutical organizations prioritize natural bioactive agents for drug development, the inclusion of high-purity kaempferol in oncology pipelines has gained momentum. This clinical urgency is highlighted by the American Cancer Society's January 2025 'Cancer Facts & Figures 2025' report, which projected approximately 2,041,910 new cancer cases in the United States for that year. Furthermore, the World Health Organization's 'World Health Statistics 2025' report from May 2025 attributes at least 43 million annual deaths to noncommunicable diseases, reinforcing the global need for accessible, plant-derived medical solutions.

In parallel, the market is being reshaped by the escalating demand for kaempferol-fortified nutraceuticals and dietary supplements, driven by a consumer paradigm shift toward plant-based preventative healthcare. This trend extends the commercial reach of flavonoids from niche medical uses to mainstream functional foods aimed at metabolic health and immune support. Manufacturers are responding by enhancing products with bioavailable kaempferol to attract health-conscious consumers seeking clean-label ingredients. The robust nature of this consumer appetite is supported by the general transition to plant-derived goods; according to the Good Food Institute's '2024 State of the Industry' report released in June 2025, global retail sales of plant-based meat, seafood, and dairy hit 28.6 billion dollars, providing a thriving environment for integrating functional botanicals like kaempferol into everyday consumer items.

Market Challenge

The economic feasibility of large-scale manufacturing stands as a formidable barrier that directly impedes the expansion of the "Global Kaempferol Market." Isolating high-purity kaempferol involves complex technical processes that frequently result in low recovery rates from raw plant material, inevitably driving up production costs. These high operational expenses force suppliers to set premium prices for the ingredient, significantly reducing its appeal for mass-market applications where profit margins are tight. Consequently, developers in the general functional food and beverage industries often bypass kaempferol in favor of more affordable synthetic antioxidants, thereby confining the ingredient's commercial presence to specialized, high-end products rather than allowing it to evolve into a volume-driven commodity.

This pricing constraint creates a disconnect between supply capabilities and the strong consumer demand for preventative health solutions. While the appetite for wellness products is extensive, the inability to produce kaempferol cost-effectively prevents it from becoming a staple in daily health regimens. The magnitude of this missed market potential is illustrated by recent industry data; according to the Council for Responsible Nutrition, 75 percent of Americans reported using dietary supplements in 2024. Although this high usage rate indicates a massive potential audience, the prohibitive costs associated with high-purity kaempferol restrict its penetration into this widespread consumer base, effectively capping the overall speed of market growth.

Market Trends

The rise of Biosynthetic Production via Metabolic Engineering marks a transformative change in the supply chain for high-value flavonoids, offering a solution to the limitations of traditional agricultural extraction. Manufacturers are increasingly abandoning solvent-based isolation methods, which are plagued by seasonal variability and low yields, in favor of microbial fermentation platforms that employ genetically modified bacteria or yeast to generate consistent, pharmaceutical-grade kaempferol. This technological advancement allows for the scalable production of bioactive compounds independent of raw plant biomass availability, ensuring a stable supply for industrial needs. The financial backing for this production shift is substantial; SynBioBeta's '2025 Investment Report' from May 2025 notes that venture investment in the synthetic biology sector rebounded to 12.2 billion dollars year-to-date in 2024, signaling strong confidence in bio-manufacturing technologies.

Concurrently, the Integration into Clean-Label Anti-Aging Skincare is broadening the ingredient's commercial scope beyond dietary supplements and into the lucrative personal care market. Formulators are aggressively adding kaempferol to premium topical products, leveraging its ability to mitigate UV-induced skin damage and neutralize free radicals to meet the growing consumer preference for science-backed, plant-derived beauty solutions. This sector represents a massive avenue for market penetration, underpinned by the scale and resilience of the beauty industry. According to the 'Annual Report 2024' by Cosmetics Europe, published in June 2025, the European personal care and cosmetics market generated retail sales of 104 billion euros in 2024, establishing a vast and stable demand landscape for functional bioactive constituents like kaempferol.

Key Market Players

  • Aktin Chemicals Inc
  • PromoCell.
  • Cambridge Isotope Laboratories.
  • FoodChem.
  • Shaanxi NHK Technology.
  • Spectrum Chemical Mfg. Corp.
  • LGC Standards.
  • FUJIFILM Wako Chemicals U.S.A Corporation.
  • AppliChem GmbH.
  • Qingdao Hosun Biological Technology Co. Ltd

Report Scope

In this report, the Global Kaempferol Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Kaempferol Market, By Purity

  • 10%
  • 20%
  • 50%
  • 95%
  • 98%

Kaempferol Market, By Application

  • Food & Beverages
  • Cosmetics
  • Pharmaceuticals
  • Dietary Supplements
  • Others

Kaempferol Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Kaempferol Market.

Available Customizations:

Global Kaempferol Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Kaempferol Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Purity (10%, 20%, 50%, 95%, 98%)
    • 5.2.2. By Application (Food & Beverages, Cosmetics, Pharmaceuticals, Dietary Supplements, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Kaempferol Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Purity
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Kaempferol Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Purity
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Kaempferol Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Purity
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Kaempferol Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Purity
        • 6.3.3.2.2. By Application

7. Europe Kaempferol Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Purity
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Kaempferol Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Purity
        • 7.3.1.2.2. By Application
    • 7.3.2. France Kaempferol Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Purity
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Kaempferol Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Purity
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Kaempferol Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Purity
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Kaempferol Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Purity
        • 7.3.5.2.2. By Application

8. Asia Pacific Kaempferol Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Purity
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Kaempferol Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Purity
        • 8.3.1.2.2. By Application
    • 8.3.2. India Kaempferol Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Purity
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Kaempferol Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Purity
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Kaempferol Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Purity
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Kaempferol Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Purity
        • 8.3.5.2.2. By Application

9. Middle East & Africa Kaempferol Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Purity
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Kaempferol Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Purity
        • 9.3.1.2.2. By Application
    • 9.3.2. UAE Kaempferol Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Purity
        • 9.3.2.2.2. By Application
    • 9.3.3. South Africa Kaempferol Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Purity
        • 9.3.3.2.2. By Application

10. South America Kaempferol Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Purity
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Kaempferol Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Purity
        • 10.3.1.2.2. By Application
    • 10.3.2. Colombia Kaempferol Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Purity
        • 10.3.2.2.2. By Application
    • 10.3.3. Argentina Kaempferol Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Purity
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Kaempferol Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Aktin Chemicals Inc
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. PromoCell.
  • 15.3. Cambridge Isotope Laboratories.
  • 15.4. FoodChem.
  • 15.5. Shaanxi NHK Technology.
  • 15.6. Spectrum Chemical Mfg. Corp.
  • 15.7. LGC Standards.
  • 15.8. FUJIFILM Wako Chemicals U.S.A Corporation.
  • 15.9. AppliChem GmbH.
  • 15.10. Qingdao Hosun Biological Technology Co. Ltd

16. Strategic Recommendations

17. About Us & Disclaimer